140 related articles for article (PubMed ID: 12518722)
21. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome.
Krauss T; Augustin HG; Osmers R; Meden H; Unterhalt M; Kuhn W
Obstet Gynecol; 1998 Sep; 92(3):457-60. PubMed ID: 9721789
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.
Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Pabinger-Fasching I; Mannhalter C; Jilma B; Speiser W
Thromb Res; 1997 Sep; 87(6):501-10. PubMed ID: 9330432
[TBL] [Abstract][Full Text] [Related]
23. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
24. Prediction of recurrent venous thromboembolism by measuring ProC Global.
Eichinger S; Hron G; Hirschl M; Bialonczyk C; Minar E; Kollars M; Kyrle PA
Thromb Haemost; 2007 Dec; 98(6):1232-6. PubMed ID: 18064319
[TBL] [Abstract][Full Text] [Related]
25. ProC Global: the first functional screening assay for the complete protein C pathway.
Dati F; Hafner G; Erbes H; Prellwitz W; Kraus M; Niemann F; Noah M; Wagner C
Clin Chem; 1997 Sep; 43(9):1719-23. PubMed ID: 9299966
[TBL] [Abstract][Full Text] [Related]
26. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
Miranda ML; Macher HC; Muñoz-Hernández R; Vallejo-Vaz A; Moreno-Luna R; Villar J; Guerrero JM; Stiefel P
Am J Hypertens; 2013 Dec; 26(12):1377-80. PubMed ID: 24103646
[TBL] [Abstract][Full Text] [Related]
27. The relationship between pregnancy induced hypertension and congenital thrombophilia.
Demir SC; Evruke C; Ozgunen T; Kadayifci O; Altintas U; Kokangul S
Saudi Med J; 2006 Aug; 27(8):1161-6. PubMed ID: 16883445
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based indications for thrombophilia screening.
Lindhoff-Last E; Luxembourg B
Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
[TBL] [Abstract][Full Text] [Related]
29. Maternal thrombophilia and the risk of recurrence of preeclampsia.
Facchinetti F; Marozio L; Frusca T; Grandone E; Venturini P; Tiscia GL; Zatti S; Benedetto C
Am J Obstet Gynecol; 2009 Jan; 200(1):46.e1-5. PubMed ID: 18845284
[TBL] [Abstract][Full Text] [Related]
30. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls.
Karakus S; Bozoklu Akkar O; Yildiz C; Sancakdar E; Cetin M; Cetin A
Arch Gynecol Obstet; 2016 Feb; 293(2):351-9. PubMed ID: 26138305
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
33. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype.
Gemmati D; Serino ML; Scapoli GL
Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366
[TBL] [Abstract][Full Text] [Related]
34. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
35. Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome.
Dogan OO; Simsek Y; Celen S; Danisman N
J Obstet Gynaecol Res; 2011 Jun; 37(6):527-33. PubMed ID: 21375667
[TBL] [Abstract][Full Text] [Related]
36. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study.
Moroni G; Doria A; Giglio E; Imbasciati E; Tani C; Zen M; Strigini F; Zaina B; Tincani A; Gatto M; de Liso F; Grossi C; Meroni PL; Cabiddu G; Messa P; Ravani P; Mosca M
J Autoimmun; 2016 Nov; 74():194-200. PubMed ID: 27373903
[TBL] [Abstract][Full Text] [Related]
37. Increased frequency of genetic thrombophilia in women with complications of pregnancy.
Kupferminc MJ; Eldor A; Steinman N; Many A; Bar-Am A; Jaffa A; Fait G; Lessing JB
N Engl J Med; 1999 Jan; 340(1):9-13. PubMed ID: 9878639
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway.
Bin Hanif T; Anwar J; Idrees M
J Ayub Med Coll Abbottabad; 2011; 23(1):89-91. PubMed ID: 22830156
[TBL] [Abstract][Full Text] [Related]
39. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study.
Mello G; Parretti E; Marozio L; Pizzi C; Lojacono A; Frusca T; Facchinetti F; Benedetto C
Hypertension; 2005 Dec; 46(6):1270-4. PubMed ID: 16246971
[TBL] [Abstract][Full Text] [Related]
40. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
